Causes of Death and Mortality Trends in Individuals with Thalassemia in the United States, 1999-2020

References

• Shafique F, Ali S, Almansouri T, et al. Thalassemia, a human blood disorder. Braz J Biol. 2021;83:e246062. doi:10.1590/1519-6984.246062.
   Google Scholar
• Angastiniotis M, Lobitz S. Thalassemias: an overview. Int J Neonatal Screen. 2019;5(1):16. doi:10.3390/ijns5010016
   PubMed Web of Science ®Google Scholar
• Aydinok Y. Thalassemia. Hematology. 2012;17(Suppl 1):S28–31. doi:10.1179/102453312X13336169155295
   PubMed Web of Science ®Google Scholar
• Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487. doi:10.2471/blt.06.036673
   PubMed Web of Science ®Google Scholar
• Kattamis A, Forni GL, Aydinok Y, Viprakasit V. Changing patterns in the epidemiology of beta-thalassemia. Eur J Haematol. 2020;105(6):692–703. doi:10.1111/ejh.13512
   PubMed Web of Science ®Google Scholar
• Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of beta-thalassemias and hemoglobin E disorders. Expert Rev Hematol. 2010;3(1):103–117. doi:10.1586/ehm.09.74
   PubMed Web of Science ®Google Scholar
• Sayani FA, Kwiatkowski JL. Increasing prevalence of thalassemia in America: implications for primary care. Ann Med. 2015;47(7):592–604. doi:10.3109/07853890.2015.1091942
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Viprakasit V, Taher AT, et al. A Phase 3 trial of luspatercept in patients with transfusion-dependent beta-Thalassemia. N Engl J Med. 2020;382(13):1219–1231. doi:10.1056/NEJMoa1910182
   PubMed Web of Science ®Google Scholar
• Locatelli F, Thompson AA, Kwiatkowski JL, et al. Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-Thalassemia. N Engl J Med. 2021;386(5):415–427. doi:10.1056/NEJMoa2113206
   PubMedGoogle Scholar
• Instructions for Classification of Underlying and Multiple Causes of Death - Section I - 2021. Centers for disease control and prevention. Available from.: https://www.cdc.gov/nchs/nvss/manuals/2a-sectioni-2021.htm#:~:text=Any%20cause%20of%20death%20that,a%20contributory%20cause%20of%20death.&text=Also%20known%20as%20terminal%20cause,(a)%20in%20Part%20I. Accessed Aug 28, 2023.
   Google Scholar
• Alexander KM, Orav J, Singh A, et al. Geographic disparities in reported us amyloidosis mortality from 1979 to 2015: potential underdetection of cardiac amyloidosis. JAMA Cardiol. 2018;3(9):865–870. doi:10.1001/jamacardio.2018.2093
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Shah NS, Passman R, Greenland P, Lloyd-Jones DM, Khan SS. Trends in cardiovascular mortality related to atrial fibrillation in the United States, 2011 to 2018. J Am Heart Assoc. 2021;10(15):e020163. doi:10.1161/JAHA.120.020163
   PubMedGoogle Scholar
• Kobo O, Van Spall HGC, Mamas MA. Urban-rural disparities in diabetes-related mortality in the USA 1999-2019. Diabetologia. 2022;65(12):2078–2083. doi:10.1007/s00125-022-05785-4
   PubMedGoogle Scholar
• Bender MA, Yusuf C, Davis T, et al. Newborn screening practices and alpha-Thalassemia detection - United States, 2016. MMWR Morb Mortal Wkly Rep. 2020;69(36):1269–1272. doi:10.15585/mmwr.mm6936a7
   PubMedGoogle Scholar
• Bender MA, Hulihan M, Dorley MC, Aguinaga MDP, Ojodu J, Yusuf C. Newborn screening practices for beta-Thalassemia in the United States. Int J Neonatal Screen. 2021;7(4):83. doi:10.3390/ijns7040083
   PubMedGoogle Scholar
• Pepe A, Meloni A, Capra M, et al. Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging. Haematologica. 2011;96(1):41–47. doi:10.3324/haematol.2009.019042
   PubMed Web of Science ®Google Scholar
• Aessopos A, Berdoukas V, Tsironi M. The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management. Eur J Haematol. 2008;80(2):93–106. doi:10.1111/j.1600-0609.2007.01018.x
   PubMedGoogle Scholar
• Sidney S, Quesenberry CP Jr, Jaffe MG, Sorel M, Go AS, Rana JS. Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015. BMC Cardiovasc Disord. 2017;17(1):192. doi:10.1186/s12872-017-0630-2
   PubMedGoogle Scholar
• Lanas F, Soto A. Trends in mortality from ischemic heart disease in the region of the Americas, 2000-2019. Glob Heart. 2022;17(1):53. doi:10.5334/gh.1144
   PubMedGoogle Scholar
• Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA. 2021;325(18):1829–1830. doi:10.1001/jama.2021.5469
   PubMed Web of Science ®Google Scholar
• Forni GL, Gianesin B, Musallam KM, et al. Overall and complication-free survival in a large cohort of patients with beta-thalassemia major followed over 50 years. Am J Hematol. 2023;98(3):381–387. doi:10.1002/ajh.26798
   PubMed Web of Science ®Google Scholar
• Zurlo M, De Stefano P, Borgna-Pignatti C, et al. SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR. Lancet. 1989;334(8653):27–30. doi:10.1016/S0140-6736(89)90264-X
   Web of Science ®Google Scholar
• Musallam KM, Vitrano A, Meloni A, et al. Survival and causes of death in 2033 patients with non-transfusion-dependent beta-thalassemia. Haematologica. 2021;106(9):2489–2492. doi:10.3324/haematol.2021.278684
   PubMed Web of Science ®Google Scholar
• Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361–2371. doi:10.1016/j.jacc.2022.11.005
   PubMed Web of Science ®Google Scholar
• Russo V, Melillo E, Papa AA, Rago A, Chamberland C, Nigro G. Arrhythmias and sudden cardiac death in beta-thalassemia major patients: noninvasive diagnostic tools and early markers. Cardiol Res Pract. 2019;2019:9319832. doi:10.1155/2019/9319832
   PubMedGoogle Scholar
• Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49. doi:10.3322/caac.21820
   PubMed Web of Science ®Google Scholar
• Chung WS, Lin CL, Lin CL, Kao CH. Thalassaemia and risk of cancer: a population-based cohort study. J Epidemiol Community Health. 2015;69(11):1066–1070. doi:10.1136/jech-2014-205075
   PubMed Web of Science ®Google Scholar
• Hodroj MH, Bou-Fakhredin R, Nour-Eldine W, Noureldine HA, Noureldine MHA, Taher AT. Thalassemia and malignancy: an emerging concern? Blood Rev. 2019;37:100585. doi:10.1016/j.blre.2019.06.002
   PubMed Web of Science ®Google Scholar
• Vichinsky EP, MacKlin EA, Waye JS, Lorey F, Olivieri NF. Changes in the epidemiology of thalassemia in north America: a new minority disease. Pediatrics. 2005;116(6):e818–25. doi:10.1542/peds.2005-0843
   PubMed Web of Science ®Google Scholar
• Vlok M, Buckley HR, Miszkiewicz JJ, et al. Forager and farmer evolutionary adaptations to malaria evidenced by 7000 years of thalassemia in Southeast Asia. Sci Rep. 2021;11(1):5677. doi:10.1038/s41598-021-83978-4
   PubMedGoogle Scholar
• (MD) B. Genes and Disease [Internet]. National Center for Biotechnology Information (US). Available from: https://www.ncbi.nlm.nih.gov/books/NBK22200/. Accessed Aug 21, 2023.
   Google Scholar
• Mary Hanna JB Immigrants from Asia in the United States. Migration Policy Institute. Available from: https://www.migrationpolicy.org/article/immigrants-asia-united-states-2020#:~:text=In%20the%202015%2D19%20period,residing%20in%20the%20United%20States. Accessed Sep 1, 2023.
   Google Scholar
• Abby Budiman NGR Key facts about Asian Americans, a diverse and growing population. Available from: https://www.pewresearch.org/short-reads/2021/04/29/key-facts-about-asian-americans/. Accessed Sep 2, 2023.
   Google Scholar
• Gaziev J, Lucarelli G. Hematopoietic stem cell transplantation for thalassemia. Curr Stem Cell Res Ther. 2011;6(2):162–169. doi:10.2174/157488811795495413
   PubMed Web of Science ®Google Scholar